Patents by Inventor Marian R. Wachtel

Marian R. Wachtel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6942861
    Abstract: The present invention describes the isolation and purification of histidine-tagged functional portions of intimin (his-tagged intimin or his-intimin), a protein associated with the ability of certain strains of pathogenic bacteria to adhere to epithelial cells. The invention further describes the use of intimin as an antigen to promote a protective immune response. In addition, the invention describes the combination of intimin with one or more other antigens and administration of the combination to promote a protective immune response against intimin and the one or more antigens. One aspect of the invention is the administration of intimin to target specific epithelial cells to promote a protective immune response to intimin proteins. Additional aspects of the invention include the use of intimin or intimin combined with one or more antigens and administration of the combination to target gastrointestinal mucosa and stimulate an immune response.
    Type: Grant
    Filed: April 18, 1997
    Date of Patent: September 13, 2005
    Assignee: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: Marian L. McKee, Alison D. O'Brien, Marian R. Wachtel
  • Patent number: 6881411
    Abstract: This invention satisfies needs in the art by providing intimin, the Enterohemorrhagic Escherichia coli (EHEC) adherence protein, alone or as a fusion protein with one or more other antigens, expressed by transgenic plants and the use of those plants as vehicles for stimulating a protective immune response against EHEC and the one or more other antigens. Various plant species are transformed to protect various animal species and also humans against EHEC, against pathogens expressing intimin-like proteins, and against pathogens expressing any of the one or more other antigens to which intimin may be fused. The eae gene encoding intimin, a functional portion thereof, or a recombination that encodes a fusion protein is put under the control of a constitutive plant promoter in a plasmid and the plasmid is introduced into plants by the type of transformation appropriate for the particular plant species.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: April 19, 2005
    Assignee: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: C. Neal Stewart, Jr., Marian L. McKee, Alison D. O'Brien, Marian R. Wachtel
  • Publication number: 20030147902
    Abstract: This invention satisfies needs in the art by providing intimin, the Enterohemorrhagic Escherichia coli (EHEC) adherence protein, alone or as a fusion protein with one or more other antigens, expressed by transgenic plants and the use of those plants as vehicles for stimulating a protective immune response against EHEC and the one or more other antigens. Various plant species are transformed to protect various animal species and also humans against EHEC, against pathogens expressing intimin-like proteins, and against pathogens expressing any of the one or more other antigens to which intimin may be fused.
    Type: Application
    Filed: May 20, 2002
    Publication date: August 7, 2003
    Applicant: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: C. Neal Stewart, Marian L. McKee, Alison D. O'Brien, Marian R. Wachtel
  • Patent number: 6406885
    Abstract: This invention satisfies needs in the art by providing intimin, the Enterohemorrhagic Escherichia coli (EHEC) adherence protein, alone or as a fusion protein with one or more other antigens, expressed by transgenic plants and the use of those plants as vehicles for stimulating a protective immune response against EHEC and the one or more other antigens. Various plant species are transformed to protect various animal species and also humans against EHEC, against pathogens expressing intimin-like proteins, and against pathogens expressing any of the one or more other antigens to which intimin may be fused. The eae gene encoding intimin, a functional portion thereof, or a recombination that encodes a fusion protein is put under the control of a constitutive plant promoter in a plasmid and the plasmid is introduced into plants by the type of transformation appropriate for the particular plant species.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: June 18, 2002
    Assignee: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: C. Neal Stewart, Jr., Marian L. McKee, Alison D. O'Brien, Marian R. Wachtel
  • Publication number: 20020006407
    Abstract: The present invention describes the isolation and purification of histidine-tagged functional portions of intimin (his-tagged intimin or his-intimin), a protein associated with the ability of certain strains of pathogenic bacteria to adhere to epithelial cells. The invention further describes the use of intimin as an antigen to promote a protective immune response. In addition, the invention describes the combination of intimin with one or more other antigens and administration of the combination to promote a protective immune response against intimin and the one or more antigens.
    Type: Application
    Filed: April 18, 1997
    Publication date: January 17, 2002
    Applicant: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: MARIAN L. MCKEE, ALISON D. O'BRIEN, MARIAN R. WACHTEL
  • Patent number: 6261561
    Abstract: This invention satisfies needs in the art by providing intimin, the Enterohemorrhagic Escherichia coli (EHEC) adherence protein, alone or as a fusion protein with one or more other antigens, expressed by transgenic plants and the use of those plants as vehicles for stimulating a protective immune response against EHEC and the one or more other antigens. Various plant species are transformed to protect various animal species and also humans against EHEC, against pathogens expressing intimin-like proteins, and against pathogens expressing any of the one or more other antigens to which intimin may be fused. The eae gene encoding intimin, a functional portion thereof, or a recombination that encodes a fusion protein is put under the control of a constitutive plant promoter in a plasmid and the plasmid is introduced into plants by the type of transformation appropriate for the particular plant species.
    Type: Grant
    Filed: April 18, 1997
    Date of Patent: July 17, 2001
    Assignee: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: C. Neal Stewart, Jr., Marian L. McKee, Alison D. O'Brien, Marian R. Wachtel